What is the half-life of Rosuvastatin (Crestor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rosuvastatin Half-Life

Rosuvastatin has an elimination half-life of approximately 19 hours, making it one of the longest-acting statins available. 1, 2

Pharmacokinetic Profile

  • The elimination half-life ranges from 13 to 21 hours in humans, with most sources citing approximately 19 hours as the standard value 1, 2, 3, 4
  • Peak plasma concentrations (Tmax) are reached 3 to 5 hours after oral administration under fasting conditions 1, 2, 5
  • The absolute oral bioavailability is approximately 20% 2, 5

Clinical Implications of the Long Half-Life

  • The extended half-life of 19 hours allows for once-daily dosing and provides sustained HMG-CoA reductase inhibition throughout the 24-hour period 3, 6
  • Rosuvastatin's long half-life makes it suitable for alternate-day dosing regimens (e.g., Monday-Wednesday-Friday) in patients who cannot tolerate daily statin therapy, particularly those experiencing myalgias 7
  • When discontinuing rosuvastatin before surgery or procedures, the 19-hour half-life should be considered to ensure adequate drug clearance, similar to recommendations for other long-acting medications 1

Comparison to Other Statins

  • Rosuvastatin has the longest half-life among commonly used statins: atorvastatin (14 hours), pitavastatin (12 hours), fluvastatin (3 hours), pravastatin (1.8 hours), lovastatin (2-3 hours), and simvastatin (2 hours) 1
  • The prolonged half-life, combined with high potency, distinguishes rosuvastatin from shorter-acting statins like simvastatin and lovastatin (half-lives of 2-3 hours) 1, 3

Metabolism and Excretion Characteristics

  • Rosuvastatin is not extensively metabolized; approximately 10% undergoes metabolism, primarily via CYP2C9 (not CYP3A4) 1, 2
  • Following oral administration, rosuvastatin and its metabolites are primarily excreted in feces (90%), with approximately 10% renal excretion 1, 2
  • The drug demonstrates minimal accumulation with repeated dosing despite its long half-life 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.